{"id":"hydroxychloroquine-with-azithromycin","safety":{"commonSideEffects":[{"rate":"10%","effect":"Nausea"},{"rate":"5%","effect":"Diarrhea"},{"rate":"5%","effect":"Abdominal pain"},{"rate":"5%","effect":"Vomiting"},{"rate":"5%","effect":"Headache"},{"rate":"5%","effect":"Dizziness"},{"rate":"5%","effect":"Fatigue"},{"rate":"5%","effect":"Insomnia"},{"rate":"1%","effect":"Allergic reactions"},{"rate":"1%","effect":"Cardiac arrhythmias"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Hydroxychloroquine has been shown to have immunomodulatory effects, while Azithromycin has been used to treat various bacterial infections.","oneSentence":"Hydroxychloroquine is a chloroquine derivative that inhibits heme polymerase, while Azithromycin is a macrolide antibiotic that inhibits protein synthesis.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T04:02:10.739Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Malaria"},{"name":"Lupus"},{"name":"Rheumatoid Arthritis"},{"name":"COVID-19"}]},"trialDetails":[{"nctId":"NCT07443436","phase":"PHASE2","title":"Immunomodulatory Treatment of Interstitial Lung Disease Associated With Surfactant Related Gene Variants","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2026-10-01","conditions":"Interstitial Lung Disease","enrollment":30},{"nctId":"NCT05894954","phase":"PHASE3","title":"Precision Medicine Approach for Early Dementia & Mild Cognitive Impairment","status":"COMPLETED","sponsor":"Alzheimer's Prevention and Reversal Project, Inc.","startDate":"2023-07-31","conditions":"Mild Cognitive Impairment, Dementia, Mild","enrollment":73},{"nctId":"NCT04390152","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of Intravenous Wharton's Jelly Derived Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Due to COVID 19","status":"TERMINATED","sponsor":"BioXcellerator","startDate":"2020-01-13","conditions":"Acute Respiratory Distress Syndrome","enrollment":6},{"nctId":"NCT02735707","phase":"PHASE3","title":"Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia","status":"RECRUITING","sponsor":"UMC Utrecht","startDate":"2016-04-11","conditions":"Community-acquired Pneumonia, Influenza, COVID-19","enrollment":20000},{"nctId":"NCT04341727","phase":"PHASE3","title":"Hydroxychloroquine,Hydroxychloroquine,Azithromycin in the Treatment of SARS CoV-2 Infection","status":"TERMINATED","sponsor":"Washington University School of Medicine","startDate":"2020-04-04","conditions":"Coronavirus Infection","enrollment":30},{"nctId":"NCT04334512","phase":"PHASE2","title":"A Study of Quintuple Therapy to Treat COVID-19 Infection","status":"COMPLETED","sponsor":"ProgenaBiome","startDate":"2020-06-22","conditions":"COVID-19, Corona Virus Infection, Coronavirus-19","enrollment":118},{"nctId":"NCT04381936","phase":"PHASE3","title":"Randomised Evaluation of COVID-19 Therapy","status":"RECRUITING","sponsor":"University of Oxford","startDate":"2020-03-19","conditions":"Severe Acute Respiratory Syndrome","enrollment":70000},{"nctId":"NCT04458948","phase":"PHASE2","title":"Non-comparative Trial of the Combination of HCQ and AZI in the Treatment of ICU Patients","status":"TERMINATED","sponsor":"University of New Mexico","startDate":"2020-03-24","conditions":"COVID-19","enrollment":28},{"nctId":"NCT05819918","phase":"","title":"Calcifediol in the Treatment of COVID 19","status":"COMPLETED","sponsor":"Maimónides Biomedical Research Institute of Córdoba","startDate":"2022-04-01","conditions":"COVID-19","enrollment":728},{"nctId":"NCT04329572","phase":"EARLY_PHASE1","title":"Efficacy and Safety of Hydroxychloroquine and Azithromycin for Patients With Moderate to Severe COVID-19","status":"SUSPENDED","sponsor":"Azidus Brasil","startDate":"2020-04-23","conditions":"COVID-19","enrollment":400},{"nctId":"NCT04348474","phase":"EARLY_PHASE1","title":"Efficacy and Safety of Hydroxychloroquine and Azithromycin for the Treatment of Ambulatory Patients With Mild COVID-19","status":"SUSPENDED","sponsor":"Azidus Brasil","startDate":"2020-04-20","conditions":"Covid-19","enrollment":200},{"nctId":"NCT04359953","phase":"PHASE3","title":"Efficacy of Hydroxychloroquine, Telmisartan and Azithromycin on the Survival of Hospitalized Elderly Patients With COVID-19","status":"TERMINATED","sponsor":"University Hospital, Strasbourg, France","startDate":"2020-04-25","conditions":"COVID-19 Infection","enrollment":16},{"nctId":"NCT04374903","phase":"NA","title":"Hydroxychloroquine in Combination With Sirolimus and Dexamethasone for Treating COVID-19 Patients","status":"WITHDRAWN","sponsor":"King Hussein Cancer Center","startDate":"2022-04-01","conditions":"COVID-19 Patients","enrollment":""},{"nctId":"NCT04329832","phase":"PHASE2","title":"Hydroxychloroquine vs. Azithromycin for Hospitalized Patients With Suspected or Confirmed COVID-19","status":"COMPLETED","sponsor":"Intermountain Health Care, Inc.","startDate":"2020-03-30","conditions":"COVID-19","enrollment":85},{"nctId":"NCT05302947","phase":"","title":"COVID-19 Study at the Russian Clinical and Research Center of Gerontology of the Pirogov RNRMU","status":"COMPLETED","sponsor":"Pirogov Russian National Research Medical University","startDate":"2020-02-01","conditions":"COVID-19, Mild to Moderate","enrollment":154},{"nctId":"NCT04322123","phase":"PHASE3","title":"Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-Cov-2 Virus (COVID-19)","status":"COMPLETED","sponsor":"Hospital do Coracao","startDate":"2020-04-01","conditions":"Coronavirus Infections","enrollment":667},{"nctId":"NCT04374539","phase":"PHASE2","title":"Plasma Exchange in Patients With COVID-19 Disease and Invasive Mechanical Ventilation: a Randomized Controlled Trial","status":"TERMINATED","sponsor":"Fundacion Clinic per a la Recerca Biomédica","startDate":"2020-04-29","conditions":"Coronavirus","enrollment":36},{"nctId":"NCT04394182","phase":"NA","title":"Ultra Low Doses of Therapy With Radiation Applicated to COVID-19","status":"SUSPENDED","sponsor":"Fundacion GenesisCare","startDate":"2020-04-21","conditions":"Pneumonia, Viral, Cytokine Storm","enrollment":15},{"nctId":"NCT04344444","phase":"PHASE3","title":"Treatment in Patients With Suspected or Confirmed COVID-19 With Early Moderate or Severe Disease","status":"TERMINATED","sponsor":"LCMC Health","startDate":"2020-04-13","conditions":"COVID-19","enrollment":22},{"nctId":"NCT04345861","phase":"PHASE2, PHASE3","title":"Hydroxychloroquine Plus Azithromycin Versus Hydroxychloroquine for COVID-19 Pneumonia (COVIDOC Trial)","status":"TERMINATED","sponsor":"University Hospital, Montpellier","startDate":"2020-04-11","conditions":"Coronavirus Infection, Pneumonia, Viral","enrollment":7},{"nctId":"NCT04358068","phase":"PHASE2","title":"Evaluating the Efficacy of Hydroxychloroquine and Azithromycin to Prevent Hospitalization or Death in Persons With COVID-19","status":"TERMINATED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2020-05-13","conditions":"COVID-19, SARS-CoV 2","enrollment":20},{"nctId":"NCT05118984","phase":"PHASE4","title":"Efficacy of Azithromycin in MSAF Cases to Improve Maternal and Neonatal Outcomes","status":"COMPLETED","sponsor":"Cairo University","startDate":"2021-02-16","conditions":"Meconium Stained, Azithromycin, Postpartum Endometritis","enrollment":324},{"nctId":"NCT05026801","phase":"PHASE3","title":"Azithromycin Plus Hydroxychloroquine for COVID-19 Infection","status":"WITHDRAWN","sponsor":"Iterum Therapeutics, International Limited","startDate":"2021-02-08","conditions":"Respiratory Tract Infection Viral","enrollment":""},{"nctId":"NCT04354597","phase":"NA","title":"Hydroxychloroquine and Azithromycin as Prophylaxis for Healthcare Workers Dealing With COVID19 Patients","status":"WITHDRAWN","sponsor":"King Hussein Cancer Center","startDate":"2020-05-01","conditions":"COVID-19","enrollment":""},{"nctId":"NCT04346693","phase":"PHASE3","title":"An Open Randomized Study of Dalargin Efectiveness in Combination With Leitragin Drug in Patients With Severe and Critical Manifestations of SARS-COVID-19","status":"COMPLETED","sponsor":"Burnasyan Federal Medical Biophysical Center","startDate":"2020-04-08","conditions":"Acute Respiratory Tract Infection, Acute Respiratory Insufficiency, Pneumonia","enrollment":320},{"nctId":"NCT04358081","phase":"PHASE3","title":"Hydroxychloroquine Monotherapy and in Combination With Azithromycin in Patients With Moderate and Severe COVID-19 Disease","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2020-05-01","conditions":"Covid-19","enrollment":20},{"nctId":"NCT04353180","phase":"PHASE3","title":"Assessment the Activity Value of Isotretinoin (13- Cis-Retinoic Acid ) in the Treatment of COVID-19 ( Isotretinoin in Treatment of COVID-19) (Randomized)","status":"UNKNOWN","sponsor":"Kafrelsheikh University","startDate":"2021-08","conditions":"COVID19","enrollment":100000},{"nctId":"NCT04964583","phase":"PHASE2, PHASE3","title":"Hidroxicloroquina With Azitromicina Versus Hidroxicloroquina and Placebo Int Patients With Mild COVID-19","status":"UNKNOWN","sponsor":"Coordinación de Investigación en Salud, Mexico","startDate":"2021-01-20","conditions":"Covid19","enrollment":105},{"nctId":"NCT04954040","phase":"PHASE2","title":"Prevention and Treatment With Hydroxychloroquine + Azithromycin of Acute Respiratory Syndrome Induced by COVID-19","status":"UNKNOWN","sponsor":"Maimónides Biomedical Research Institute of Córdoba","startDate":"2021-02-10","conditions":"Acute Respiratory Distress Syndrome, Covid19","enrollment":132},{"nctId":"NCT04322396","phase":"PHASE2","title":"Proactive Protection With Azithromycin and hydroxyChloroquine in Hospitalized Patients With COVID-19","status":"TERMINATED","sponsor":"Chronic Obstructive Pulmonary Disease Trial Network, Denmark","startDate":"2020-04-06","conditions":"Virus Diseases, Infection Viral, Corona Virus Infection","enrollment":117},{"nctId":"NCT04933864","phase":"PHASE1","title":"COVID-19 Treatment Using Methylene Blue and Photodynamic Therapy","status":"COMPLETED","sponsor":"I.M. Sechenov First Moscow State Medical University","startDate":"2020-04-24","conditions":"SARS-CoV-2","enrollment":60},{"nctId":"NCT04335552","phase":"PHASE2","title":"Pragmatic Factorial Trial of Hydroxychloroquine, Azithromycin, or Both for Treatment of Severe SARS-CoV-2 Infection","status":"TERMINATED","sponsor":"Duke University","startDate":"2020-04-17","conditions":"SARS-CoV-2","enrollment":11},{"nctId":"NCT04332094","phase":"PHASE2","title":"Clinical Trial of the Use of Tocilizumab for Treatment of SARS-CoV-2 Infection (COVID-19)","status":"UNKNOWN","sponsor":"Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","startDate":"2020-04-02","conditions":"COVID-19","enrollment":276},{"nctId":"NCT04365582","phase":"PHASE3","title":"OUTpatient Treatment of COVID-19 in Patients With Risk Factor for Poor Outcome","status":"WITHDRAWN","sponsor":"Fondation Hôpital Saint-Joseph","startDate":"2020-05-07","conditions":"COVID","enrollment":""},{"nctId":"NCT04459702","phase":"PHASE2","title":"A Study of Combination Therapies to Treat COVID-19 Infection","status":"WITHDRAWN","sponsor":"ProgenaBiome","startDate":"2020-07","conditions":"COVID, COVID-19, Corona Virus Infection","enrollment":""},{"nctId":"NCT04349592","phase":"NA","title":"Hydroxychloroquine With or Without Azithromycin for Virologic Cure of COVID-19","status":"COMPLETED","sponsor":"Hamad Medical Corporation","startDate":"2020-04-14","conditions":"Covid19","enrollment":456},{"nctId":"NCT04418193","phase":"","title":"Patient Preference Trial for COVID-19 (PPT-COVID)","status":"WITHDRAWN","sponsor":"Centre Hospitalier Princesse Grace","startDate":"2020-04-06","conditions":"Coronavirus","enrollment":""},{"nctId":"NCT04411433","phase":"PHASE3","title":"Efficacy and Safety of Hydroxychloroquine and Favipiravir in the Treatment of Mild to Moderate COVID-19","status":"UNKNOWN","sponsor":"Ministry of Health, Turkey","startDate":"2020-05-08","conditions":"Sars-CoV2, COVID-19","enrollment":1008},{"nctId":"NCT04646109","phase":"PHASE3","title":"Ivermectin for Severe COVID-19 Management","status":"COMPLETED","sponsor":"Afyonkarahisar Health Sciences University","startDate":"2020-05-11","conditions":"COVID-19","enrollment":66},{"nctId":"NCT04347031","phase":"PHASE2, PHASE3","title":"A Study of the Effectiveness of an Off Label Mefloquine Use for the Treatment of Patients With COVID19","status":"COMPLETED","sponsor":"Burnasyan Federal Medical Biophysical Center","startDate":"2020-04-08","conditions":"Pneumonia, Viral, Respiratory Failure","enrollment":320},{"nctId":"NCT04715295","phase":"PHASE4","title":"Safety and Efficacy of Doxycycline and Rivaroxaban in COVID-19","status":"UNKNOWN","sponsor":"Yaounde Central Hospital","startDate":"2020-10-05","conditions":"COVID-19","enrollment":200},{"nctId":"NCT04321278","phase":"PHASE3","title":"Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-CoV2 Virus (Coalition Covid-19 Brasil II)","status":"COMPLETED","sponsor":"Hospital Israelita Albert Einstein","startDate":"2020-03-28","conditions":"Coronavirus Infections, Pneumonia, Viral","enrollment":440},{"nctId":"NCT04386447","phase":"PHASE2","title":"Phase II RCT to Assess Efficacy of Intravenous Administration of Oxytocin in Patients Affected by COVID-19","status":"WITHDRAWN","sponsor":"Azienda Ospedaliero-Universitaria di Parma","startDate":"2020-09-01","conditions":"Covid-19, Corona Virus Infection, SARS-CoV 2","enrollment":""},{"nctId":"NCT04403646","phase":"NA","title":"Tannin Specific Natural Extract for COVID-19 Infection","status":"TERMINATED","sponsor":"Hospital de Clinicas José de San Martín","startDate":"2020-06-12","conditions":"COVID-19, SARS-CoV 2, Coronavirus Infection","enrollment":124},{"nctId":"NCT04405310","phase":"PHASE2","title":"Convalescent Plasma of Covid-19 to Treat SARS-COV-2 a Randomized Doble Blind 2 Center Trial","status":"COMPLETED","sponsor":"Grupo Mexicano para el Estudio de la Medicina Intensiva","startDate":"2020-05-20","conditions":"SARS Pneumonia","enrollment":42},{"nctId":"NCT04668469","phase":"NA","title":"Efficacy and Safety of Ivermectin for Treatment and Prophylaxis of COVID-19 Pandemic","status":"COMPLETED","sponsor":"Benha University","startDate":"2020-06-08","conditions":"Covid19","enrollment":600},{"nctId":"NCT04370782","phase":"PHASE4","title":"Hydroxychloroquine and Zinc With Either Azithromycin or Doxycycline for Treatment of COVID-19 in Outpatient Setting","status":"COMPLETED","sponsor":"St. Francis Hospital, New York","startDate":"2020-04-28","conditions":"COVID-19","enrollment":18},{"nctId":"NCT04361461","phase":"PHASE3","title":"Use of Hydroxychloroquine Alone or Associated for Inpatients With SARS-CoV2 Virus (COVID-19)","status":"WITHDRAWN","sponsor":"Apsen Farmaceutica S.A.","startDate":"2020-04-30","conditions":"Coronavirus Infections, SARS-CoV 2, SARS (Severe Acute Respiratory Syndrome)","enrollment":""},{"nctId":"NCT04349410","phase":"PHASE2, PHASE3","title":"The Fleming [FMTVDM] Directed CoVid-19 Treatment Protocol","status":"COMPLETED","sponsor":"The Camelot Foundation","startDate":"2020-04-11","conditions":"CoVid 19 Positive","enrollment":1800},{"nctId":"NCT04339816","phase":"PHASE3","title":"Azithromycin Added to Hydrochloroquine in Patients Admitted to Intensive Care With COVID-19: Randomised Controlled Trial","status":"TERMINATED","sponsor":"Frantisek Duska, MD, PhD","startDate":"2020-05-13","conditions":"COVID-19, Respiratory Failure","enrollment":3},{"nctId":"NCT04542694","phase":"PHASE3","title":"Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19","status":"COMPLETED","sponsor":"Promomed, LLC","startDate":"2020-05-21","conditions":"COVID-19","enrollment":200},{"nctId":"NCT04463420","phase":"NA","title":"Safety and Efficacy of PHR 160 Spray on the Outcomes of Patients With COVID-19","status":"UNKNOWN","sponsor":"Baqiyatallah Medical Sciences University","startDate":"2020-08-15","conditions":"COVID-19","enrollment":224},{"nctId":"NCT04374552","phase":"PHASE2","title":"Asymptomatic COVID-19 Trial","status":"WITHDRAWN","sponsor":"Rutgers, The State University of New Jersey","startDate":"2020-05-05","conditions":"SARS-CoV-2 Infection","enrollment":""},{"nctId":"NCT04371406","phase":"PHASE3","title":"Efficacy of Azithromycin-associated Hydroxychloroquine Therapy Given in General Practice in Early-stage Disease in COVID-19 Patients","status":"WITHDRAWN","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2020-04","conditions":"Covid-19","enrollment":""},{"nctId":"NCT04575558","phase":"PHASE2","title":"HOPE: A Trial of Hydroxichloroquine Plus Azithromycin in High Risk COVID-19","status":"WITHDRAWN","sponsor":"Latin American Cooperative Oncology Group","startDate":"2020-06-30","conditions":"Sars-CoV2","enrollment":""},{"nctId":"NCT04361422","phase":"PHASE3","title":"Isotretinoin in Treatment of COVID-19","status":"UNKNOWN","sponsor":"Tanta University","startDate":"2020-12-01","conditions":"COVID-19","enrollment":300},{"nctId":"NCT04558463","phase":"PHASE3","title":"The Effectivity and Safety of Favipiravir Compared to Oseltamivir as Adjuvant Therapy for COVID-19","status":"UNKNOWN","sponsor":"Indonesia University","startDate":"2020-04-16","conditions":"Covid19","enrollment":100},{"nctId":"NCT04395768","phase":"PHASE2","title":"International ALLIANCE Study of Therapies to Prevent Progression of COVID-19","status":"UNKNOWN","sponsor":"National Institute of Integrative Medicine, Australia","startDate":"2020-09-09","conditions":"COVID19","enrollment":200},{"nctId":"NCT04392128","phase":"PHASE2","title":"Study Evaluating the Efficacy of Hydroxychloroquine and Azithromycine in Patients With COVID-19 and Hematological Malignancies (HYACINTHE)","status":"WITHDRAWN","sponsor":"Institut de cancérologie Strasbourg Europe","startDate":"2020-09-02","conditions":"COVID19, Hematologic Malignancy","enrollment":""},{"nctId":"NCT04452617","phase":"","title":"Safety of Short-term Hydroxychloroquine Plus Azithromycin Treatment in Critically Ill Patients With Severe COVID-19","status":"COMPLETED","sponsor":"Institut Mutualiste Montsouris","startDate":"2020-03-19","conditions":"COVID-19","enrollment":40},{"nctId":"NCT04530422","phase":"PHASE3","title":"Efficacy of Sofosbuvir Plus Ledipasvir in Egyptian Patients With COVID-19 Compared to Standard Treatment","status":"COMPLETED","sponsor":"Almaza Military Fever Hospital","startDate":"2020-04-15","conditions":"Covid19","enrollment":250},{"nctId":"NCT04502342","phase":"PHASE2","title":"Add on to Azythromycine, Phytomedicine and/or Antimalarial Drug vs Hydroxychloroquine in Uncomplicated COVID-19 Patients","status":"UNKNOWN","sponsor":"Institute for Research and Development of Medicinal and Food Plants of Guinea","startDate":"2020-06-01","conditions":"Covid19","enrollment":30},{"nctId":"NCT04501965","phase":"PHASE2","title":"Phytomedicines Versus Hydroxychloroquine as an Add on Therapy to Azythromycin in Asymptomatic Covid-19 Patients","status":"UNKNOWN","sponsor":"Institute for Research and Development of Medicinal and Food Plants of Guinea","startDate":"2020-06-01","conditions":"Covid19","enrollment":231},{"nctId":"NCT04395170","phase":"PHASE2, PHASE3","title":"Convalescent Plasma (PC) and Human Intravenous Anti-COVID-19 Immunoglobulin (IV Anti COVID-19 IgG) in Patients Hospitalized for COVID-19.","status":"UNKNOWN","sponsor":"Lifefactors Zona Franca, SAS","startDate":"2020-09","conditions":"Coronavirus Disease 2019 (COVID-19)","enrollment":75},{"nctId":"NCT04453501","phase":"","title":"Anti Infective Agents Impact in COVID-19 Pneumonia","status":"COMPLETED","sponsor":"Centre d'Investigation Clinique et Technologique 805","startDate":"2020-03-02","conditions":"COVID, Pneumonia, Viral","enrollment":132},{"nctId":"NCT04344457","phase":"PHASE1, PHASE2","title":"Evaluate the Efficacy and Safety of Oral Hydroxychloroquine, Indomethacin and Zithromax in Subjects With Mild Symptoms of COVID-19","status":"UNKNOWN","sponsor":"Perseverance Research Center, LLC","startDate":"2020-04-16","conditions":"COVID-19","enrollment":80},{"nctId":"NCT04441424","phase":"NA","title":"Convalescent Plasma Therapy on Critically-ill Novel Coronavirus (COVID-19) Patients","status":"COMPLETED","sponsor":"Alkarkh Health Directorate-Baghdad","startDate":"2020-04-03","conditions":"IMMUNOTHERAPY","enrollment":49},{"nctId":"NCT04405921","phase":"PHASE3","title":"Hydroxychloroquine, Azithromycin in the Treatment of Covid-19","status":"UNKNOWN","sponsor":"Centre Hôpital Universitaire Farhat Hached","startDate":"2020-07","conditions":"SARS-CoV-2 Pneumonia, COVID-19","enrollment":200},{"nctId":"NCT04347512","phase":"PHASE3","title":"EVALUATION OF THE EFFICACY OF THE HYDROXYCHLOROQUINE-AZITHROMYCIN COMBINATION IN THE IN THE PREVENTION OF COVID-19 RELATED SDRA","status":"WITHDRAWN","sponsor":"University Hospital, Strasbourg, France","startDate":"2020-06-02","conditions":"Sars-CoV-2, Community-Acquired Pneumonia,COVID-19","enrollment":""},{"nctId":"NCT04412746","phase":"","title":"Covid-19 and Diabetes in West of Algeria","status":"UNKNOWN","sponsor":"Laboratoire De Recherche Sur Le Diabete, Université de Tlemcen","startDate":"2020-04-01","conditions":"Coronavirus Infections, Diabetes Mellitus, Prevalence","enrollment":100},{"nctId":"NCT04341870","phase":"PHASE2, PHASE3","title":"Study of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients: Sarilumab, Azithromycin, Hydroxychloroquine Trial - CORIMUNO-19 - VIRO","status":"SUSPENDED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2020-04-11","conditions":"COVID19, SARS-CoV-2 Infection","enrollment":27},{"nctId":"NCT04368351","phase":"","title":"Bacteriotherapy in the Treatment of COVID-19","status":"UNKNOWN","sponsor":"University of Roma La Sapienza","startDate":"2020-03-01","conditions":"COVID, Pneumonia, Diarrhea","enrollment":70},{"nctId":"NCT04366089","phase":"PHASE2","title":"Oxygen-Ozone as Adjuvant Treatment in Early Control of COVID-19 Progression and Modulation of the Gut Microbial Flora","status":"UNKNOWN","sponsor":"Roberto Poscia MD, PhD","startDate":"2020-03-26","conditions":"COVID, SARS-CoV 2, Pneumonia, Viral","enrollment":152},{"nctId":"NCT04355052","phase":"PHASE3","title":"Open Label Study to Compare Efficacy, Safety and Tolerability of Hydroxychloroquine Combined With Azithromycin Compared to Hydroxychloroquine Combined With Camostat Mesylate and to \"no Treatment\" in SARS CoV 2 Virus","status":"UNKNOWN","sponsor":"Sheba Medical Center","startDate":"2020-04-11","conditions":"COVID - 19","enrollment":250},{"nctId":"NCT04323345","phase":"PHASE3","title":"Efficacy of Natural Honey Treatment in Patients With Novel Coronavirus","status":"UNKNOWN","sponsor":"Misr University for Science and Technology","startDate":"2020-04-15","conditions":"COVID-19","enrollment":1000},{"nctId":"NCT04341207","phase":"PHASE2","title":"Epidemiology of SARS-CoV-2 and Mortality to Covid19 Disease in French Cancer Patients","status":"UNKNOWN","sponsor":"Gustave Roussy, Cancer Campus, Grand Paris","startDate":"2020-04-03","conditions":"Cancer & COVID 19","enrollment":1000},{"nctId":"NCT04334382","phase":"PHASE3","title":"Hydroxychloroquine vs. Azithromycin for Outpatients in Utah With COVID-19","status":"UNKNOWN","sponsor":"Intermountain Health Care, Inc.","startDate":"2020-04-02","conditions":"COVID-19","enrollment":1550},{"nctId":"NCT04328272","phase":"PHASE3","title":"Effectiveness of Hydroxychloroquine in Covid-19 Patients","status":"UNKNOWN","sponsor":"Prof. Dr. Umar Farooq","startDate":"2020-03-28","conditions":"COVID19","enrollment":75}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":141,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Azithromycin"],"phase":"phase_2","status":"active","brandName":"Hydroxychloroquine with Azithromycin","genericName":"Hydroxychloroquine with Azithromycin","companyName":"Coordinación de Investigación en Salud, Mexico","companyId":"coordinaci-n-de-investigaci-n-en-salud-mexico","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Hydroxychloroquine is a chloroquine derivative that inhibits heme polymerase, while Azithromycin is a macrolide antibiotic that inhibits protein synthesis. Used for Malaria, Lupus, Rheumatoid Arthritis.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}